News FDA declines to approve AbbVie's Botox follow-up AbbVie's bid to bring a rapid and shorter-acting botulinum toxin product to the US market has been knocked back by the FDA.
News UK awards COVID-19 grant to surgery software developer The UK government is providing funding to bring a software tool used to monitor patients during surgery to market “as soon as possible”, says its developer.
News GSK sells anaesthetics portfolio to Aspen Companies also end collaboration in sub-Saharan Africa.
News argenx's Forte acquisition delivers coeliac trial win argenx's CD122 inhibitor FB102, added to its pipeline through the $2.2bn acquisition of Forte, is moving into phase 3 testing for coeliac disease.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
